Bishkek, July 6, 2026 /Kabar/. Kyrgyzstan is at the forefront of building a modern warehouse that meets international GPP (Good Pharmacy Practice) standards, Health Minister Damirbek Osmonov told Kabar.
As the minister noted, large global pharmaceutical companies do not sell their drugs to countries that do not have such warehouses. Their goal is not just a one-time profit, but to ensure business continuity and stability.
"If drugs are delivered to places where proper conditions are not met and temperature control is violated, they lose their properties and become ineffective for patients. Ultimately, this damages the reputation of the manufacturers themselves, which is why they impose strict logistics requirements before selling. "Constructing a warehouse that meets GPP standards will allow us to directly contract with all the world's largest pharmaceutical giants and receive their medications first-hand," Osmonov said.
According to the head of the department, the Ministry of Health has already reached agreements with leading international companies. In particular, pharmaceutical giant Pfizer has expressed its willingness to supply a wide range of medications at reduced prices. Negotiations are also underway to bring Sanofi back to the Kyrgyz market, and agreements have already been signed with the Swiss pharmaceutical giant Roche.